跳转至内容
Merck
CN

810230P

Avanti

C6-NBD Safingol

Avanti Research - A Croda Brand

别名:

N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-L-threo-sphinganine

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C30H51N5O6
化学文摘社编号:
分子量:
577.76
UNSPSC Code:
12352211
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

C6-NBD Safingol, Avanti Research - A Croda Brand 810230P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 50 μg (810230P-50ug)

manufacturer/tradename

Avanti Research - A Croda Brand 810230P

shipped in

dry ice

storage temp.

−20°C

General description

Safingol belongs to the lysosphingolipid class and is the synthetic L-threo-stereoisomer of (D-erythro-) sphinganine.

Biochem/physiol Actions

Safingol, a competitive inhibitor of sphingosine kinase 1, exhibits anticancer activity. It is known to increase antitumor activity of cisplatin in xenograft experiments.

Packaging

5 mL Amber Glass Screw Cap Vial (810230P-50ug)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Still not finding the right product?

Explore all of our products under


存储类别

11 - Combustible Solids

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Jesse Coward et al.
Autophagy, 5(2), 184-193 (2008-12-23)
Safingol, the synthetic L-threo-stereoisomer of endogenous (D-erythro-) sphinganine, is an inhibitor of protein kinase C and sphingosine kinase in vitro, and in some cell types has been implicated in ceramide generation and induction of apoptosis. Utilizing electron microscopy, acridine orange
Mark A Dickson et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 17(8), 2484-2492 (2011-01-25)
Sphingosine 1-phosphate (S1P) is an important mediator of cancer cell growth and proliferation. Production of S1P is catalyzed by sphingosine kinase 1 (SphK). Safingol, (l-threo-dihydrosphingosine) is a putative inhibitor of SphK. We conducted a phase I trial of safingol (S)
Synthesis of threo-beta-aminoalcohols from aminoaldehydes via chelation-controlled additions. Total synthesis of l-threo sphingosine and safingol
Jung ME and Yi SW
Tetrahedron Letters, 53(32), 4216-4220 (2012)



全球贸易项目编号

货号GTIN
810230P-50UG04061835190386